BioSphere Medical Embosphere
This article was originally published in The Gray Sheet
Executive Summary
Bioengineered microspheres gain 510(k) clearance for the minimally invasive treatment of vascular malformations and tumors via embolization. Embosphere will be directly marketed by a team of reps supported by a clinical team. BioSphere launched Phase I trials of the device in uterine artery embolization for uterine fibroid treatment in January